Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DC Vaccination for Glioblastoma Multiforme
NCT01567202Phase 2Unknown
- Sponsor
- Huashan Hospital
- Start
- Mar 2012
- Primary completion
- Nov 2020
- Modality
- Prophylactic Vaccines, Whole Cell Cancer Vaccines, Dendritic Cell Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of autologous dendritic cell vaccine in glioblastoma multiforme (GBM), sponsored by Huashan Hospital. Status: unknown.
02
Drugs
autologous dendritic cell vaccine
03
Conditions
glioblastoma multiforme (GBM)
Beyond the preview
Go deeper on NCT01567202.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01567202.